tm logo

Monitor this mark

View On USPTO

XOLAIR
Live/Registered
Section 71 & 15 – ACCEPTED AND ACKNOWLEDGED

on 19 Nov 2020

Last Applicant/ Owned by

NOVARTIS AG

CH-4002

Basel

CH

4002

Serial Number

79143692 filed on 05th Feb 2014

Registration Number

4590913 registered on 26th Aug 2014

in the Principal Register

Correspondent Address

Maury M. Tepper, III

Maury M. Tepper, III Tepper & Eyster, PLLC

Raleigh, NC 27609

United States

Filing Basis

1. filing basis filed as 66 a

Disclaimer

NO DATA

XOLAIR

Pharmaceutical preparations for the prevention and treatment of urticaria

Classification Information

Class [005]
Pharmaceutical Products

Pharmaceutical preparations for the prevention and treatment of urticaria

First Use Date in General

N/A

First Use Date in Commerce

N/A

Mark Details

Serial Number

No 79143692

Mark Type

No Service/Collective Mark

Attorney Docket Number

No

44D Filed

No

44D Current

No

44E filed

No

44E Current

No

66A Filed

Yes

66A Current

Yes

Current Basis

No

No Basis

No

Design Code(s)

26.17.01 -

Straight line(s), band(s) or bar(s)

26.17.09 -

Curved line(s), band(s) or bar(s)

26.17.25 -

Other lines, bands or bars

Legal History

Show more

Status DateAction Taken
17th Jun 2024TEAS SECTION 71 RECEIVED
20th Oct 2023INTERNATIONAL REGISTRATION RENEWED
26th Aug 2023COURTESY REMINDER - SEC. 71 (10-YR) E-MAILED
19th Nov 2020NOTICE OF ACCEPTANCE OF SEC. 71 & 15 - E-MAILED
19th Nov 2020REGISTERED - SEC. 71 ACCEPTED & SEC. 15 ACK.
19th Nov 2020CASE ASSIGNED TO POST REGISTRATION PARALEGAL
06th Jul 2020TEAS SECTION 71 & 15 RECEIVED
09th Oct 2019COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
26th Aug 2019COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
19th Feb 2015FINAL DECISION TRANSACTION PROCESSED BY IB